Itau Unibanco Holding S.A.’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.3M Buy
+109,207
New +$14.8M 0.33% 63
2025
Q3
Sell
-1,000
Closed -$1.28K 448
2025
Q2
$1.28K Buy
+1,000
New +$79.8K ﹤0.01% 377
2025
Q1
Sell
-13,022
Closed -$1.17M 465
2024
Q4
$1.17M Buy
+13,022
New +$1.26M 0.04% 110
2020
Q1
Sell
-1,125
Closed -$107K 902
2019
Q4
$107K Buy
+1,125
New +$97.3K 0.01% 493

Other funds holding XBI

Itau Unibanco Holding S.A.'s XBI Position: Q2 2026 in Review

Itau Unibanco Holding S.A. opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 109,207 shares worth $17.3M. The stake represents 0.33% of the portfolio and ranks #63 among its holdings. This is a return to the name: Itau Unibanco Holding S.A. previously reported a position in XBI as recently as Q2 2025.

Itau Unibanco Holding S.A. first reported a position in XBI in Q4 2019 and has held it in 4 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Itau Unibanco Holding S.A. held 109,207 shares of State Street SPDR S&P Biotech ETF worth $17.3M as of Q2 2026.
  • State Street SPDR S&P Biotech ETF was a new Itau Unibanco Holding S.A. position in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.33% of Itau Unibanco Holding S.A.'s portfolio in Q2 2026, its #63 holding.
  • Itau Unibanco Holding S.A. first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 4 quarters since.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2026, filed 14 Aug 2026.